Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$8.0 million.

  • Profound Medical's Profit After Tax rose 1482.11% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.3 million, marking a year-over-year increase of 4447.16%. This contributed to the annual value of -$27.8 million for FY2024, which is 179.01% up from last year.
  • Per Profound Medical's latest filing, its Profit After Tax stood at -$8.0 million for Q3 2025, which was up 1482.11% from -$15.7 million recorded in Q2 2025.
  • Over the past 5 years, Profound Medical's Profit After Tax peaked at $7.4 million during Q2 2023, and registered a low of -$48.0 million during Q4 2023.
  • Moreover, its 3-year median value for Profit After Tax was -$6.9 million (2024), whereas its average is -$8.2 million.
  • Over the last 5 years, Profound Medical's Profit After Tax had its largest YoY gain of 8969.01% in 2024, and its largest YoY loss of 26831.42% in 2024.
  • Quarter analysis of 3 years shows Profound Medical's Profit After Tax stood at -$48.0 million in 2023, then skyrocketed by 89.69% to -$4.9 million in 2024, then crashed by 61.25% to -$8.0 million in 2025.
  • Its last three reported values are -$8.0 million in Q3 2025, -$15.7 million for Q2 2025, and -$10.7 million during Q1 2025.